BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22810649)

  • 1. MTHFR polymorphisms and ovarian cancer risk: a meta-analysis.
    Liu L; Liao SG; Wang YJ
    Mol Biol Rep; 2012 Nov; 39(11):9863-8. PubMed ID: 22810649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.
    Xiong Y; Bian C; Lin X; Wang X; Xu K; Zhao X
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32639550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between MTHFR gene polymorphism and the risk of ovarian cancer: a meta-analysis of the literature.
    Pu D; Jiang SW; Wu J
    Curr Pharm Des; 2014; 20(11):1632-8. PubMed ID: 24720627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer.
    Lv L; Wang P; Sun B; Chen G
    Tumour Biol; 2014 Jan; 35(1):227-37. PubMed ID: 23897558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: a meta-analysis.
    Bai R; Liu W; Zhao A; Zhao Z; Jiang D
    Mol Biol Rep; 2013 Mar; 40(3):2419-30. PubMed ID: 23229495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relevance of MTHFR C677T, A1298C, and MTRR A66G polymorphisms with response to male infertility in Asians: A meta-analysis.
    Shi TL; Wu Y; Li Y; Chen ZF; Ma YN; Zhang ZT; Zhang YH; Zhang L
    Medicine (Baltimore); 2019 Feb; 98(8):e14283. PubMed ID: 30813130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and male infertility risk: An updated meta-analysis.
    Han LJ; He XF; Ye XH
    Medicine (Baltimore); 2020 Dec; 99(51):e23662. PubMed ID: 33371103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.
    Ma C; Liu Y; Zhang W; Liu P
    Mol Biol Rep; 2013 Mar; 40(3):2061-8. PubMed ID: 23329275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between C677T and A1298C polymorphisms of MTHFR and susceptibility to rheumatoid arthritis: a systematic review and meta-analysis.
    Yuan Y; Shao W; Li Y
    Rheumatol Int; 2017 Apr; 37(4):557-569. PubMed ID: 28175955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between MTHFR gene polymorphisms (C677T, A1298C) and genetic susceptibility to prostate cancer: a meta-analysis.
    Chen PL; Li WT; Wang J; Jiang YD; Wu P; Chen T; Zheng SB
    Genet Mol Res; 2015 Dec; 14(4):19191-202. PubMed ID: 26782572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
    Yi K; Yang L; Lan Z; Xi M
    Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of MTHFR C677T and A1298C Polymorphisms on Migraine Susceptibility: A Meta-Analysis of 26 Studies.
    Liu L; Yu Y; He J; Guo L; Li H; Teng J
    Headache; 2019 Jun; 59(6):891-905. PubMed ID: 31045246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility.
    Xia LZ; Liu Y; Xu XZ; Jiang PC; Ma G; Bu XF; Zhang YJ; Yu F; Xu KS; Li H
    World J Gastroenterol; 2014 Aug; 20(32):11429-38. PubMed ID: 25170232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case-control studies.
    Liang H; Yan Y; Li T; Li R; Li M; Li S; Qin X
    Tumour Biol; 2014 Feb; 35(2):1695-701. PubMed ID: 24078451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTHFR C677T and A1298C polymorphisms and cervical carcinoma susceptibility: meta-analyses based on 4,421 individuals.
    Zhuo WL; Zhang L; Ling JJ; Zhu Y; Chen ZT
    Mol Biol Rep; 2012 Sep; 39(9):8723-32. PubMed ID: 22711309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in breast cancer.
    Zhong S; Chen Z; Yu X; Li W; Tang J; Zhao J
    Mol Biol Rep; 2014 Sep; 41(9):5775-85. PubMed ID: 24973876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASSOCIATION OF MTHFR A1298C POLYMORPHISM WITH BREAST CANCER AND/OR OVARIAN CANCER RISK: AN UPDATED META-ANALYSIS.
    Liu W; Li Y; Li R; Han X; Ma Y; Liu B; Kong X
    Afr J Tradit Complement Altern Med; 2016; 13(5):72-86. PubMed ID: 28487897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of MTHFR C677T and A1298C gene polymorphisms: association with the risk of hepatocellular carcinoma.
    Qi YH; Yao LP; Cui GB; Liang J; Shao QJ; Yan LF; Du P
    Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):172-80. PubMed ID: 24316043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of methylenetetrahydrofolate reductase (
    Yang R; Pu D; Tan R; Wu J
    Arch Endocrinol Metab; 2022 Sept 08; 66(4):551-581. PubMed ID: 35758831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and essential hypertension: a systematic review and meta-analysis.
    Wu YL; Hu CY; Lu SS; Gong FF; Feng F; Qian ZZ; Ding XX; Yang HY; Sun YH
    Metabolism; 2014 Dec; 63(12):1503-11. PubMed ID: 25458833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.